Theseus Pharmaceuticals (THRX) Earnings Date, Estimates & Call Transcripts → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free thrx Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTHRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.THRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Theseus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.33)($0.33)($0.33)Q2 20241($0.35)($0.35)($0.35)Q3 20241($0.37)($0.37)($0.37)Q4 20241($0.39)($0.39)($0.39)FY 20244($1.44)($1.44)($1.44) Get Theseus Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for THRX and its competitors with MarketBeat's FREE daily newsletter. Theseus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/17/2023Q3 2023($0.35)($0.31)+$0.04($0.31)--8/10/2023Q2 2023($0.34)($0.34)-($0.34)--5/11/2023Q1 2023($0.42)($0.34)+$0.08($0.34)--3/9/2023Q4 2022($0.44)($0.35)+$0.09($0.35)--11/3/2022Q3 2022($0.34)($0.38)($0.04)($0.38)--8/11/2022Q2 2022($0.29)($0.30)($0.01)($0.30)-- Get the Latest News and Ratings for THRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theseus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($0.25)($0.27)($0.02)($0.27)--3/10/2022Q4 2021($0.23)($0.24)($0.01)($0.24)--11/15/2021Q3 2021($0.23)($5.16)($4.93)($5.16)-- Theseus Pharmaceuticals Earnings - Frequently Asked Questions How much profit does Theseus Pharmaceuticals generate each year? Theseus Pharmaceuticals (NASDAQ:THRX) has a recorded net income of -$50.61 million. THRX has generated -$1.34 earnings per share over the last four quarters. What is Theseus Pharmaceuticals's EPS forecast for next year? Theseus Pharmaceuticals's earnings are expected to decrease from ($1.41) per share to ($1.61) per share in the next year. More Earnings Resources from MarketBeat Related Companies: PRQR Earnings SYRS Earnings MACK Earnings ACRV Earnings NGM Earnings VTGN Earnings KNTE Earnings ACIU Earnings BDTX Earnings ASMB Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:THRX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theseus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.